Author:
Jacobson Arnold F.,Narula Jagat
Publisher
Springer Berlin Heidelberg
Reference91 articles.
1. Agostini D, Belin A, Amar MH, Darlas Y, Hamon M, Grollier G, Potier JC, Bouvard G (2000) Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a [123I]-MIBG scintigraphic study. J Nucl Med 41:845–851
2. Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, Unlu M, Estorch M, Banerjee G, Jacobson AF (2008) I-123-MIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 35:535–546
3. Arora R, Ferrick KJ, Nakata T, Kaplan RC, Rozengarten M, Latif F, Ng K, Marcano V, Heller S, Fisher JD, Travin MI (2003) I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol 10:121–131
4. Backs J, Haunstetter A, Gerber SH, Metz J, Borst MM, Strasser RH et al (2001) The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J Mol Cell Cardiol 33:461–472
5. Bailey JJ, Berson AS, Handelsman H, Hodges M (2001) Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 38:1902–1911